Leiwen Chen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The Series D+ round was led by GTJA Investment Group and Beijing-based state capital investor Kingray Capital.

Leiwen chenJunshi biosciencesNational medical products administrationYangzhou guojin groupInvestment groupDrug administrationYangzhou cityLilly asia venturesNew drug applicationKingray capitalEikon therapeuticsHong kong listedWuxi apptecCenova venturesDecheng capital